Emergent BioSolutions to Participate in Cantor Fitzgerald Global Healthcare Conference

GAITHERSBURG, Md., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the Cantor Fitzgerald Global Healthcare Conference 2019 to be held in New York from October 2 to 4.

Presentation date and time will be updated on the Emergent website www.emergentbiosolutions.com under “Investors” as the information becomes available.

The company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcast will be available both live and by replay, accessible from the Emergent website.

About Emergent BioSolutionsEmergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats. We aspire to be a Fortune 500 company recognized for protecting and enhancing life, driving innovation, and living our values. Additional information about the company may be found at www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280[email protected]

Media Contact:Lynn KiefferVice President, Corporate Communications240-631-3391[email protected]

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• BNP PARIBAS GROUP: SUDAN LITIGATION STATEMENT FROM BNP PARIBAS
• She Made it – the Youngest South African Woman to Swim the Channel